News Room
Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal
Deals and Financings Jiangsu Hengrui Pharma (SHA: 600275) out-licensed global rights (ex-China) for a novel anti-inflammatory to ONE Bio (OTC:ONBI)…
As COVID hospitalizations rise, Pfizer and Moderna say updated shots show promise against Eris variant
Amid an uptick in COVID-19 hospitalizations, vaccine makers say the updated shots they’ve developed for fall are proving effective against…
US FDA approves higher dose of Regeneron’s eye disease drug Eylea
© Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland,…
Analysis-China’s sputtering economy curbs outlook for diesel demand for rest of 2023
By Andrew Hayley BEIJING (Reuters) - China's muted economic growth in 2023 as its post-COVID recovery underwhelms has crimped the…
Turkey begins rolling back costly FX-protected deposits
ANKARA (Reuters) -Turkey's central bank began rolling back on Sunday a growing and costly scheme that protects lira deposits from…
Former Disney Exec says Bob Iger, ‘creates the right culture’
Watch full video on YouTube
Can Expensive, American-Made Weapons Like F-16s Turn The Tide In Ukraine’s War Against Russia?
Watch full video on YouTube
Equitable Holdings: Undervalued Against Sector Averages With A Great Dividend (NYSE:EQH)
Introduction Operating in the diversified financial services industry, Equitable Holdings, Inc. (NYSE:EQH) has done very well for itself as it…